Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Lui

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Frontiers in Psychiatry|March 1, 2021
Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic ReviewYazen Alnefeesi, Ashley Siegel, Leanna M W Lui, et al.
Journal of Psychiatric Research|May 27, 2022
The abuse liability of ketamine: A scoping review of preclinical and clinical studiesTuyen T Le, Isabel Pazos Cordero, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research|December 28, 2020
The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysisJiaqi Xiong, Orly Lipsitz, David Chen-Li, et al.
Psychiatry Research|February 22, 2021
Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and applicationLinas Wilkialis, Nelson Rodrigues, Amna Majeed, et al.
Journal of Affective Disorders|May 9, 2021
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine TreatmentRoger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Journal of Psychiatric Research|March 28, 2021
Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic reviewAshley N Siegel, Joshua D Di Vincenzo, Elisa Brietzke, et al.
Journal of Affective Disorders|May 8, 2020
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic ReviewHartej Gill, Sabine El-Halabi, Amna Majeed, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative reviewDavid Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.
International Journal of Environmental Research and Public Health|April 21, 2018
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar DisorderCarola Rong, Caroline Park, Joshua D Rosenblat, et al.
Journal of Affective Disorders|September 1, 2022
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic reviewAnastasia Levinta, Shakila Meshkat, Roger S McIntyre, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Psychiatry|March 1, 2021
Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic ReviewYazen Alnefeesi, Ashley Siegel, Leanna M W Lui, et al.
Journal of Psychiatric Research|May 27, 2022
The abuse liability of ketamine: A scoping review of preclinical and clinical studiesTuyen T Le, Isabel Pazos Cordero, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research|December 28, 2020
The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysisJiaqi Xiong, Orly Lipsitz, David Chen-Li, et al.
Psychiatry Research|February 22, 2021
Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and applicationLinas Wilkialis, Nelson Rodrigues, Amna Majeed, et al.
Journal of Affective Disorders|May 9, 2021
Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine TreatmentRoger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, et al.
Journal of Psychiatric Research|March 28, 2021
Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic reviewAshley N Siegel, Joshua D Di Vincenzo, Elisa Brietzke, et al.
Journal of Affective Disorders|May 8, 2020
The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic ReviewHartej Gill, Sabine El-Halabi, Amna Majeed, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 25, 2022
Ketamine as potential treatment for postpartum depression: A narrative reviewDavid Chen-Li, Leanna M W Lui, Joshua D Rosenblat, et al.
International Journal of Environmental Research and Public Health|April 21, 2018
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar DisorderCarola Rong, Caroline Park, Joshua D Rosenblat, et al.
Journal of Affective Disorders|September 1, 2022
The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic reviewAnastasia Levinta, Shakila Meshkat, Roger S McIntyre, et al.
Pageof 8